Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration.
The COVID-19 booster drive in the U.S. is losing steam, worrying health experts.
Health officials say Alabama will have a limited number of doses of a new drug that can be used to treat COVID-19.
A federal appeals court panel has ruled that President Joe Biden’s vaccine mandate for larger private employers can take effect.
The U.S. is opening COVID-19 vaccine boosters to all adults, and urging them for anyone 50 and older.
The U.S. is moving to open up COVID-19 booster shots to all adults, letting them choose another dose of either the Pfizer or Moderna vaccine.
Alabama health officials say kids could begin receiving coronavirus vaccinations by November 6th.
Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections.
The Food and Drug Administration has paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine.
WASHINGTON (AP) – A government advisory panel has endorsed extra doses of all three of the nation’s vaccines. Advisers to the Centers for Disease Control and Prevention also said Thursday that people could choose a different company’s brand for that next shot. Certain people who received Pfizer vaccinations months ago already are eligible for a booster. The advisers said certain…
